Gilead Sciences Inc said on Tuesday it has signed non-exclusive licensing pacts with five generic drugmakers based in India and Pakistan to expand the supply of its experimental COVID-19 treatment remdesivir.
from Zee News :World https://ift.tt/2AofD08
Tuesday, 12 May 2020
Related Posts:
Anti-malaria drug hydroxychloroquine championed by Donald Trump for coronavirus COVID-19 treatment fails another test, finds study
US Vice President Mike Pence in self-isolation after aide tests positive for coronavirus COVID-19
US unemployment rate surges to 14.7 per cent, worst since Great Depression
Kuwait imposes 20-day 'total curfew' from May 10 to curb coronavirus COVID-19
0 comments: